Implement and Test Visual Consent Template and Process

Eligibility Criteria for Patients: * Adult participants (18+) eligible for one of three participating trials at Washington University, University of Utah, or University of North Carolina at Chapel Hill. The eligibility criteria for the main trials are below: * UNC: * Basal-like PDAC Treated with Gemcitabine, Erlotinib, and Nab-paclitaxel (PANGEA) trial inclusion criteria: * Written informed consent was obtained to participate in the study and HIPAA authorization for release of personal health information. * Participant is willing and able to comply with study procedures based on the judgment of the investigator. * Age ≥ 18 years at the time of consent. * Eastern Cooperative Oncology Group (ECOG) Performance Status of 0-1. * Consent to a mandatory pre-study biopsy if archival tissue is not available or sufficient. * Participants with a prior or concurrent malignancy whose natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of the investigational regimen. * Washington University: * Returning Research Results That Indicate Risk of Alzheimer Disease Dementia to Healthy Participants in Longitudinal Studies (WeSHARE) * Participants of the Knight Alzheimer Disease Research Center. * Participants with available results from an Alzheimer Disease blood biomarker test. * Participants who agreed to be contacted for additional research studies. * University of Utah: * Huntsman Cancer Institute Total Cancer Care * Participants who have been diagnosed with any type of tumor or cancer. * Participants with genetic predispositions or family history of cancer or tumors. * Participant volunteers willing to share samples and data for research. Eligibility Criteria for Research Staff: * Research staff/coordinators of one of the three participating trials at Washington University, University of Utah, or University of North Carolina at Chapel Hill.